Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
复制标题
DOI:
10.1016/j.neuron.2016.01.042
复制
发表时间:
2016-03-16
期刊:
影响因子:
16.2
通讯作者:
Sestan N
中科院分区:
文献类型:
--
作者:
Olmos-Serrano JL;Kang HJ;Tyler WA;Silbereis JC;Cheng F;Zhu Y;Pletikos M;Jankovic-Rapan L;Cramer NP;Galdzicki Z;Goodliffe J;Peters A;Sethares C;Delalle I;Golden JA;Haydar TF;Sestan N
Trisomy 21, or Down syndrome (DS), is the most common genetic cause of developmental delay and intellectual disability. To gain insight into the underlying molecular and cellular pathogenesis, we conducted a multi-region transcriptome analysis of DS and euploid control brains spanning from mid-fetal development to adulthood. We found genome-wide alterations in the expression of a large number of genes, many of which exhibited temporal and spatial specificity and were associated with distinct biological processes. In particular, we uncovered co-dysregulation of genes associated with oligodendrocyte differentiation and myelination that were validated via cross-species comparison to Ts65Dn trisomy mice. Furthermore, we show that hypomyelination present in Ts65Dn mice is in part due to cell-autonomous effects of trisomy on oligodendrocyte differentiation and results in slower neocortical action potential transmission. Together, these results identify defects in white matter development and function in DS and provide a transcriptional framework for further investigating DS neuropathogenesis.